loxoprofen has been researched along with Pseudotumor Cerebri in 1 studies
loxoprofen: RN given refers to parent cpd without isomeric designation; structure in first source
loxoprofen : A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-[(2-oxocyclopentyl)methyl]phenyl group. A prodrug that is rapidly converted into its active trans-alcohol metabolite following oral administration.
Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, S | 1 |
| Nagafuchi, Y | 1 |
| Fujio, K | 1 |
1 other study available for loxoprofen and Pseudotumor Cerebri
| Article | Year |
|---|---|
Retro-odontoid Pseudotumor Associated with Sjögren Syndrome and Systemic Lupus Erythematosus Serology.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Humans; Lupus Coagulation Inhibitor; Lupus Erythemat | 2018 |